Flowvana drug-eluting bypass graft
Spring 2020
In spring 2020 I worked with a team of students to design a drug-eluting bypass for patients with severe peripheral artery disease. This graft also minimizes the risk of neointimal hyperplasia (restenosis) through a slow release drug included in the graft wall. The project included problem definition, market and stakeholder analysis, concept generation, applying biofluid mechanics knowledge to COMSOL simulations, and CAD through SolidWorks to achieve specific engineering goals. A Pugh Matrix was used to arrive at the final preliminary design. I also gained experience creating and reading engineering drawings and presenting multiple product pitches. I took the lead on this project and was often looked to as the decision-making voice due to my ability to logically think through problems and consolidate information in easy to understand, detail-oriented ways. Final report demonstrates successful simulations and engineering goals met.
Project Outcomes











